Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2014)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; DUARTE, GERALDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1038/tpj.2014.26
- Subjects: INIBIDORES DE ENZIMAS; METALOPROTEINASES; POLIMORFISMO; HIPERTENSÃO NA GRAVIDEZ
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 14, n. 6, p. 535-541, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
LUIZON, M. R. et al. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 14, n. 6, p. 535-541, 2014Tradução . . Disponível em: https://doi.org/10.1038/tpj.2014.26. Acesso em: 30 abr. 2024. -
APA
Luizon, M. R., Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Lacchini, R., et al. (2014). Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 14( 6), 535-541. doi:10.1038/tpj.2014.26 -
NLM
Luizon MR, Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Lacchini R, Cavalli R de C, Duarte G, Tanus-Santos JE. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2014 ; 14( 6): 535-541.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1038/tpj.2014.26 -
Vancouver
Luizon MR, Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Lacchini R, Cavalli R de C, Duarte G, Tanus-Santos JE. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2014 ; 14( 6): 535-541.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1038/tpj.2014.26 - Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
- Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
- Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
- Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- eNOS tag SNP haplotypes in hypertensive disorders of pregnancy
- Evaluation of maternal-fetal doppler parameters and of whole blood nitrite throughout gestation
- Vitamin D receptor polimorphisms in hipertensive disorders of pregnancy
- Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period
Informações sobre o DOI: 10.1038/tpj.2014.26 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
